209 related articles for article (PubMed ID: 15186939)
1. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results.
Fobi G; Gardon J; Kamgno J; Aimard-Favennec L; Lafleur C; Gardon-Wendel N; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2005 Apr; 99(4):279-89. PubMed ID: 15708387
[TBL] [Abstract][Full Text] [Related]
3. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin.
Cooper PJ; Awadzi K; Ottesen EA; Remick D; Nutman TB
J Infect Dis; 1999 Mar; 179(3):738-42. PubMed ID: 9952390
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions to ivermectin treatment in Simulium neavei-transmitted onchocerciasis.
Kipp W; Bamhuhiiga J; Rubaale T; Büttner DW
Am J Trop Med Hyg; 2003 Dec; 69(6):621-3. PubMed ID: 14740878
[TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
7. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
8. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
9. Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.
Pion SD; Clément MC; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):520-8. PubMed ID: 15251400
[TBL] [Abstract][Full Text] [Related]
10. Community treatment with ivermectin for onchocerciasis in the east Usambara mountains.
Mwetta E; Hills E
East Afr Med J; 1994 Dec; 71(12):790-1. PubMed ID: 7705249
[TBL] [Abstract][Full Text] [Related]
11. Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin.
Cooper PJ; Schwartz LB; Irani AM; Awadzi K; Guderian RH; Nutman TB
J Infect Dis; 2002 Nov; 186(9):1307-13. PubMed ID: 12402200
[TBL] [Abstract][Full Text] [Related]
12. Individuals living in an onchocerciasis focus and treated three-monthly with ivermectin develop fewer new onchocercal nodules than individuals treated annually.
Campillo JT; Chesnais CB; Pion SDS; Gardon J; Kamgno J; Boussinesq M
Parasit Vectors; 2020 May; 13(1):258. PubMed ID: 32414398
[TBL] [Abstract][Full Text] [Related]
13. Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial.
Gardon J; Boussinesq M; Kamgno J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO
Lancet; 2002 Jul; 360(9328):203-10. PubMed ID: 12133654
[TBL] [Abstract][Full Text] [Related]
14. [Ivermectin in the treatment of onchocerciasis: feasibility, compliance and efficacy of a mass treatment].
Awissi D; Heuschkel C; Banla M; Schulz-Key H
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):739-49. PubMed ID: 1819423
[TBL] [Abstract][Full Text] [Related]
15. The chemotherapy of onchocerciasis. XIX: The clinical and laboratory tolerance of high dose ivermectin.
Awadzi K; Opoku NO; Addy ET; Quartey BT
Trop Med Parasitol; 1995 Jun; 46(2):131-7. PubMed ID: 8525285
[TBL] [Abstract][Full Text] [Related]
16. Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial.
Opoku NO; Bakajika DK; Kanza EM; Howard H; Mambandu GL; Nyathirombo A; Nigo MM; Kasonia K; Masembe SL; Mumbere M; Kataliko K; Larbelee JP; Kpawor M; Bolay KM; Bolay F; Asare S; Attah SK; Olipoh G; Vaillant M; Halleux CM; Kuesel AC
Lancet; 2018 Oct; 392(10154):1207-1216. PubMed ID: 29361335
[TBL] [Abstract][Full Text] [Related]
17. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
Awadzi K; Dadzie KY; Kläger S; Gilles HM
Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
[TBL] [Abstract][Full Text] [Related]
18. The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus.
Awadzi K; Edwards G; Duke BO; Opoku NO; Attah SK; Addy ET; Ardrey AE; Quartey BT
Ann Trop Med Parasitol; 2003 Mar; 97(2):165-78. PubMed ID: 12803872
[TBL] [Abstract][Full Text] [Related]
19. Onchocerciasis-associated limb swelling in a traveler returning from Cameroon.
Ezzedine K; Malvy D; Dhaussy I; Steels E; Castelein C; De Dobbeler G; Heenen M
J Travel Med; 2006; 13(1):50-3. PubMed ID: 16412109
[TBL] [Abstract][Full Text] [Related]
20. The effect of repeated doses of ivermectin on adult female Onchocerca volvulus in Sierra Leone.
Chavasse DC; Post RJ; Lemoh PA; Whitworth JA
Trop Med Parasitol; 1992 Dec; 43(4):256-62. PubMed ID: 1293732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
